Valuation: Mecure Industries PLC

Market Cap 225B 169M 152M 142M 129M 242M 16.1B 243M 1.7B 665M 8.35B 635M 621M 26.87B P/E 2024
23.9x
P/E 2025 40.4x
Enterprise Value 274B 206M 185M 173M 157M 294M 19.6B 296M 2.07B 810M 10.17B 773M 756M 32.71B EV / Sales 2024
1.99x
EV / Sales 2025 3.99x
Free-Float
12.71%
Yield 2024
1.08%
Yield 2025 0.49%
3 months-34.23%
6 months-8.62%
Current year-13.80%
1 week 56.2
Extreme 56.2
56.2
1 month 56.2
Extreme 56.2
56.2
Current year 54.55
Extreme 54.55
104
1 year 24.95
Extreme 24.95
104
3 years 5.73
Extreme 5.73
104
5 years 5.73
Extreme 5.73
104
10 years 5.73
Extreme 5.73
104
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+97.89% - 169M
+4.05%+2.05%+49.34%+96.73% 1,040B
+1.37%-2.36%+32.22%+60.19% 599B
+3.51%+4.69%+23.98%+92.95% 485B
+3.71%+3.33%+74.19%+41.67% 350B
+3.09%+3.03%+29.59%+47.09% 345B
+2.82%+2.20%+17.90%+40.67% 272B
+3.40%+0.99%-3.44%+12.10% 244B
+2.91%+3.12%+44.97%+48.49% 223B
+3.03%+3.65%+28.46%+92.18% 183B
Average +2.80%+2.14%+39.51%+59.12% 374.3B
Weighted average by Cap. +3.20%+2.31%+36.80%+67.95%

Financials

2024 2025
Net sales 46.03B 34.63M 31.14M 29.06M 26.34M 49.45M 3.3B 49.75M 349M 136M 1.71B 130M 127M 5.5B 77.69B 58.46M 52.56M 49.05M 44.46M 83.47M 5.56B 83.98M 589M 230M 2.89B 219M 215M 9.29B
Net income 2.33B 1.75M 1.58M 1.47M 1.33M 2.5M 167M 2.52M 17.64M 6.89M 86.54M 6.58M 6.44M 278M 6.46B 4.86M 4.37M 4.08M 3.7M 6.94M 463M 6.99M 48.97M 19.12M 240M 18.26M 17.86M 772M
Net Debt 35.77B 26.92M 24.2M 22.58M 20.47M 38.43M 2.56B 38.67M 271M 106M 1.33B 101M 98.86M 4.28B 48.85B 36.76M 33.05M 30.84M 27.95M 52.48M 3.5B 52.81M 370M 145M 1.82B 138M 135M 5.84B
Projected Income Statement - Annual - Mecure Industries PLC
Logo Mecure Industries PLC
Mecure Industries Plc is a human therapeutics company. The Company is principally in the business of manufacturing drugs, such as tablets, capsules and syrups in Nigeria under two categories namely pharmaceuticals and nutraceuticals. The Company’s Pharmaceuticals segment comprises of over 41 drugs, such as Ebu 200 and 400 (ibuprofen tablets), Laclox, Lamox (an amoxicillin formulation) and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consist of approximately 100 products, including multivitamins and dietary supplements. Its products and services include acute ailment medication, chronic ailment medication, nutraceuticals, multivitamins and a planned expansion into chemotherapy medication. It also offers mobile applications, such as the Smart Pill and Smart Buy applications. These applications serve as online pharmacies that facilitate easy purchase and delivery of Company’s products to retail customers in urban cities.
Employees
195
Date Price Change Volume
26-10-13 NGN 56.20 0.00% 8,562
26-10-12 NGN 56.20 0.00% 168,299
26-10-09 NGN 56.20 0.00% 21,628
26-10-08 NGN 56.20 0.00% 30,578
26-10-07 NGN 56.20 0.00% 34,875
  1. Stock Market
  2. Stocks
  3. MECURE Stock